Stay updated on Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Sign up to get notified when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision stamp was updated from v3.5.3 to v3.5.4, signaling a maintenance update to the record rather than a substantive change to the trial content.
    Difference
    0.3%
    Check dated 2026-05-17T10:38:56.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    No additions or deletions were reported, so the page content remains unchanged.
    Difference
    0.2%
    Check dated 2026-05-10T11:02:53.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    No changes were provided in the input for this page. Based on the supplied data, there is no update to describe.
    Difference
    0.2%
    Check dated 2026-05-03T02:13:30.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page’s footer indicates an updated ClinicalTrials.gov site/release revision from v3.5.0 to v3.5.3.
    Difference
    0.3%
    Check dated 2026-04-25T18:44:34.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page.
    Difference
    0.1%
    Check dated 2026-04-11T10:48:25.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    New study record dates added: 2026-03-31 and 2026-03-29; dates 2026-03-25 and 2026-03-04 were removed.
    Difference
    0.3%
    Check dated 2026-04-04T06:15:55.000Z thumbnail image

Stay in the know with updates to Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.